Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 22.66B | 22.66B | 18.43B | 14.34B | 10.82B | 5.17B |
Gross Profit | 8.87B | 8.87B | 4.81B | 3.13B | 2.41B | 1.45B |
EBITDA | 5.77B | 5.77B | 4.17B | 3.43B | 2.84B | 1.71B |
Net Income | 3.82B | 3.82B | 2.97B | 2.45B | 2.14B | 1.35B |
Balance Sheet | ||||||
Total Assets | 36.22B | 36.22B | 32.83B | 20.11B | 18.27B | 7.53B |
Cash, Cash Equivalents and Short-Term Investments | 15.44B | 15.44B | 13.70B | 7.89B | 6.05B | 632.45M |
Total Debt | 820.95M | 820.95M | 1.83B | 1.06B | 1.49B | 1.19B |
Total Liabilities | 6.75B | 6.75B | 7.85B | 5.44B | 6.48B | 3.93B |
Stockholders Equity | 29.46B | 29.46B | 24.98B | 14.65B | 11.78B | 3.59B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 2.66B | 1.47B | 1.68B | 1.33B | 525.07M |
Operating Cash Flow | 0.00 | 4.26B | 2.62B | 2.60B | 2.06B | 1.02B |
Investing Cash Flow | 0.00 | -1.14B | -5.77B | -1.97B | -5.56B | -1.75B |
Financing Cash Flow | 0.00 | -918.13M | 7.83B | -590.45M | 6.15B | 530.86M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | ₹268.10B | 66.74 | ― | 21.06% | 23.33% | ||
61 Neutral | $35.43B | 7.71 | -10.08% | 1.88% | 8.71% | -9.18% | |
― | ₹25.25B | ― | ― | ― | ― | ||
73 Outperform | ₹54.66B | 28.27 | 2.71% | 4.36% | 35.84% | ||
65 Neutral | ₹98.37B | 22.74 | 1.61% | 16.11% | 45.45% | ||
― | ₹141.95B | 59.88 | ― | ― | ― | ||
54 Neutral | ₹103.10B | 56.03 | 0.43% | 100.45% | 6.29% |
Affle 3i Limited announced its participation in an in-person, one-on-one analyst and investor meeting with Fidelity International in Singapore on June 24, 2025. The meeting was conducted in compliance with SEBI regulations, and no unpublished price-sensitive information was disclosed, indicating the company’s commitment to transparency and regulatory adherence.